Trials / Completed
CompletedNCT01832662
Coffee Polyphenols Antioxidants
Coffee Antioxidant Efficacy in Humans
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Société des Produits Nestlé (SPN) · Industry
- Sex
- All
- Age
- 20 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
Coffee is one of the most widely consumed beverages. It contains polyphenols (chlorogenic acids) and bioavailability of these bioactive compounds is now somewhat well understood. In addition, chlorogenic acids are known to be antioxidants in the cup, but reliable evidence remains to be observed in vivo. The objective of this trial is to understand if regular (10d) coffee intake may be beneficial on biomarkers of oxidative damage measured in urine and plasma. A secondary objective is to understand if polyphenols isolated from coffee may be as beneficial as the whole beverage in reducing oxidative stress compared to placebo
Detailed description
This is an interventional study with a crossover randomized placebo-controlled double-blind design to assess the effect of regular consumption of coffee on oxidative stress compared to placebo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | coffee | coffee, placebo enriched with polyphenols and placebo with caffeine |
| OTHER | coffee polyphenols mixed with placebo | coffee polyphenols mixed with placebo |
| OTHER | maltodextrin enriched with caffeine | maltodextrin enriched with caffeine |
Timeline
- Start date
- 2011-03-01
- Primary completion
- 2012-04-01
- Completion
- 2013-06-01
- First posted
- 2013-04-16
- Last updated
- 2014-04-21
Source: ClinicalTrials.gov record NCT01832662. Inclusion in this directory is not an endorsement.